Bernard Dardzinski, Ph.D.

Bernard Dardzinski, Ph.D.

Bernard Dardzinki

Name: Bernard Dardzinski, Ph.D.

Department of Primary Appointment: Radiology & Radiological Services
Position: USU Faculty
Title: Core PI/TIF Director

Affiliated Center: CNRM

Email: (link sends e-mail)
Office Phone: (301) 295-3247

PubMed Listing


Dr. Dardzinski is an Associate Professor in the Department of Radiology and Radiological Sciences at USUHS and the PI of the CNRM's Translational Imaging Facility at USUHS. His areas of expertise include development of magnetic resonance imaging (MRI) techniques and optimization of other imaging modalities to improve understanding of disease processes such as traumatic brain injury, stroke, and musculoskeletal disorders. He joined USUHS from the Children’s Hospital of Philadelphia, where he focused on musculoskeletal research and whole-body imaging in children. Dr. Dardzinski received his Ph.D. in Biomedical Engineering from Worcester Polytechnic Institute in 1994 where he employed nuclear magnetic resonance (NMR) to evaluate stroke and tissue oxygenation in animal models via diffusion and fluorine imaging, respectively, under the mentorship of the late Dr. Chris Sotak. He conducted his fellowship at the Pennsylvania State University at Hershey, where he collaborated with Dr. Timothy Mosher to develop “T2 mapping”, a measure of early cartilage disruption that is now widely used in musculoskeletal research and practice. He then joined the faculty at the Cincinnati Children’s Hospital Medical Center for over a decade, where for the last two years he was named Scientific Director of the Imaging Research Center in Radiology, overseeing all imaging research activities within the hospital, with an academic appointment of Professor of Pediatrics, Radiology, and Biomedical Engineering at the University of Cincinnati. Dr. Dardzinski joined Merck in 2007 as Senior Director/Research Fellow, leading a wide variety of imaging efforts across a broad range of therapeutic areas with the goal of developing novel biomarkers for prediction of outcomes in clinical trials, and for discovery of new drug targets.

Dr. Dardzinski has authored over 75 peer-reviewed publications, presented numerous invited talks, and has served on the Scientific Program and Governance Committees of the International Society for Magnetic Resonance in Medicine (ISMRM). He has further served on several NIH grant committees, abstract review committees, doctoral committees, and internal grant and investigational review boards.

Dr. Dardzinski’s research interests focus on the utility of quantitative imaging for biomarker development in disease diagnosis and for the monitoring of therapeutic efficacy in pre-clinical to clinical translational research and drug development.

Uniformed Services University of the Health Sciences
4301 Jones Bridge Road
Bethesda, MD 20814